Home > Blog

Blog | Veristat, The Science-First CRO

Gain the latest insights and trends in clinical trials, patient recruitment, data analysis, adaptive design, regulatory submissions and approvals.

Sign Up Today

3 min read

Regulatory Guidance Monthly Review - June 2021

June 2021 

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical...

READ MORE

4 min read

Planning the Way Forward in Neurodegenerative Disease Studies

Clinical trials involving gene therapies for the treatment of Central Nervous System (CNS) indications are some of the more complex in the field of gene and cell therapy (G&CT) development. During the lockdown, the Food and Drug Administration (FDA)...

READ MORE

2 min read

Regulatory Guidance Monthly Review - May 2021

May 2021 

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical device...

READ MORE

3 min read

Mental Health: Connecting Openly & Honestly

As we say goodbye to Mental Health Month in May and welcome Men’s Mental Health Month in June, there is no better time to check in with ourselves and each other.

READ MORE

1 min read

Veristat Raises >$350K For Rare Cancer Research

Team Veristat Participate in Cycle for Survival 2021 - Virtually

For the past seven years, Veristat has participated in Memorial Sloan Kettering's Cycle for Survival, the movement to beat rare cancers. Founded in partnership with Equinox fitness club...

READ MORE

2 min read

Regulatory Guidance Monthly Review - April 2021

April 2021 

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical...

READ MORE

2 min read

Regulatory Guidance Monthly Review - March 2021

March 2021 

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical...

READ MORE

3 min read

Harnessing Efficiencies in a Post-COVID World

The COVID-19 pandemic has accelerated the clinical trial communitys quest to streamline its data-driven processes in order to find new and better ways to gain flexibility and efficiency throughout the clinical development continuum.

READ MORE

2 min read

Regulatory Guidance Monthly Review - February 2021

February 2021 

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical...

READ MORE

1 min read

Regulatory Guidance Monthly Review - January 2021

January 2021 

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical...

READ MORE